Supersensitivity of alpha 2-adrenoceptors modulating [3H]5-HT release after noradrenergic denervation with DSP4.
Benkirane
S
S
Arbilla
S
S
Langer
S Z
SZ
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000588:Amines / Q000494:pharmacology*; D000818:Animals; D001596:Benzylamines / Q000494:pharmacology*; D003000:Clonidine / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D004146:Dioxanes / Q000494:pharmacology; D004558:Electric Stimulation; D006624:Hippocampus / Q000378:metabolism*; D019329:Idazoxan; D009638:Norepinephrine / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D051381:Rats; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects* / Q000502:physiology; D012701:Serotonin / Q000378:metabolism* / Q000502:physiology; D013563:Sympathectomy, Chemical
D000317:Adrenergic alpha-Antagonists; D000588:Amines; D001596:Benzylamines; D004146:Dioxanes; D011942:Receptors, Adrenergic, alpha; D012701:Serotonin; C024884:6-fluoronorepinephrine; D003000:Clonidine; C012102:DSP 4; D003891:Desipramine; D009638:Norepinephrine; D019329:Idazoxan